We are actively involved in the following therapeutic areas: Analgesia, Oncology, and Respiratory.


Analgesia is our largest therapeutic area, and we have over 15 different products currently available offering oral, transdermal and parenteral delivery of analgesia to suit the patient's needs. Over the years, we have introduced a number of products that have transformed the way we treat pain in Ireland and across the globe. In 1980 we introduced the world's first prolonged release morphine sulphate tablets, which revolutionised the treatment of cancer pain. Since then, we have brought a number of innovations to the market, including the first 7-day analgesic patch and the first opioid agonist/antagonist combination tablet.


In 2004 we launched our first oncology product, and we have gone on to acquire a number of other products in this field, which are currently in clinical trials or under assessment by the regulatory authorities.


We also have a promising respiratory franchise. For a number of years, we have marketed prolonged release oral aminophylline and theophylline, but we are now branching out into inhaled products, with a number of products set for launch in the near future.


We continuously strive to develop ways to deliver medicines to patients in a way that improves the efficacy of the medication and reduces any negative impact on the patient’s quality of life. We never lose sight of the fact that patients are, in the first instance, people. They have the normal cares, concerns and expectations that we all experience in daily life. Our aim is to provide the with therapeutic answers to their health problems so that they can life life to the the fullest extent possible. We currently focus on three therapeutic areas (pain, cancer and respiratory) which have the potential to have chronic, long-term, impact on people’s lives. We look to partnering the medical profession and the patient to manage these conditions over the long term and to seek new and ever better solutions.


Mundipharma Pharmaceuticals associated companies, Mundipharma Research Limited in Cambridge and Mundipharma Research GmbH in Germany, are young,...


What is asthma?
Asthma is a common medical condition that affects the lungs.
More specifically, asthma causes...


We are actively involved in the following therapeutic areas: Analgesia, Oncology, and Respiratory.


Analgesia is our...


Mundipharma Pharmaceuticals Limited is an Irish company and is part of a network of independent associated companies across Europe. This...

keep me informed

Keep me Informed

Receive Emails about special offers, promotions, products and news.

Mundipharma newsletter

events calendar
Events Calendar
Medical Information &

Medical Information & Adverse Events

Contact Medical Information on:

01 2063800
1800 991 830 (outside office hours)

For Adverse Events email: